{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:27:44Z","timestamp":1792661264120,"version":"4.5.0"},"reference-count":161,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Vaccines used to prevent infections have long been known to stimulate immune responses to cancer as illustrated by the approval of the Bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccine to treat bladder cancer since the 1970s. The recent approval of immunotherapies has rejuvenated this research area with reports of anti-tumor responses with existing infectious diseases vaccines used as such, either alone or in combination with immune checkpoint inhibitors. Here, we have reviewed and summarized research activities using approved vaccines to treat cancer. Data supporting a cancer therapeutic use was found for 16 vaccines. For 10 (BCG, diphtheria, tetanus, human papillomavirus, influenza, measles, pneumococcus, smallpox, typhoid and varicella-zoster), clinical trials have been conducted or are ongoing. Within the remaining 6, preclinical evidence supports further evaluation of the rotavirus, yellow fever and pertussis vaccine in carefully designed clinical trials. The mechanistic evidence for the cholera vaccine, combined with the observational data in colorectal cancer, is also supportive of clinical translation. There is limited data for the hepatitis B and mumps vaccine (without measles vaccine). Four findings are worth highlighting: the superiority of intravesical typhoid vaccine instillations over BCG in a preclinical bladder cancer model, which is now the subject of a phase I trial; the perioperative use of the influenza vaccine to limit and prevent the natural killer cell dysfunction induced by cancer surgery; objective responses following intratumoral injections of measles vaccine in cutaneous T-cell lymphoma; objective responses induced by human papillomavirus vaccine in cutaneous squamous cell carcinoma. All vaccines are intended to induce or improve an anti-tumor (immune) response. In addition to the biological and immunological mechanisms that vary between vaccines, the mode of administration and sequence with other (immuno-)therapies warrant more attention in future research.<\/jats:p>","DOI":"10.3389\/fonc.2021.688755","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T10:26:32Z","timestamp":1620901592000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":39,"title":["Repurposing Infectious Diseases Vaccines Against Cancer"],"prefix":"10.3389","volume":"11","author":[{"given":"Liese","family":"Vandeborne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Pantziarka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An M. T.","family":"Van Nuffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauthier","family":"Bouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3332\/ecancer.2018.886","article-title":"Redo_DB: The Repurposing Drugs in Oncology Database","volume":"12","author":"Pantziarka","year":"2018","journal-title":"Ecancermedicalscience"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.169","article-title":"Drug Repurposing in Oncology\u2013Patient and Health Systems Opportunities","volume":"12","author":"Bertolini","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.167","article-title":"Trends in the Global Immuno-Oncology Landscape","volume":"17","author":"Tang","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"B4","article-title":"Repurposing Infectious Pathogen Vaccines in Cancer Immunotherapy","volume-title":"Drug Repurposing","author":"Conti","year":"2020"},{"key":"B5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/PPO.0000000000000368","article-title":"Repurposing Food and Drug Administration-Approved Drugs to Promote Antitumor Immunity","volume":"25","author":"Sukhatme","year":"2019","journal-title":"Cancer J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-018-02483-3","article-title":"Bringing Down the Cost of Cancer Treatment","volume":"555","author":"Dolgin","year":"2018","journal-title":"Nature"},{"key":"B7","article-title":"Adjuvant Immunotherapy in Superficial Bladder Cancer","author":"Morales","year":"1978","journal-title":"Natl Cancer Inst Monogr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41541-019-0103-y","article-title":"Turning the Corner on Therapeutic Cancer Vaccines","volume":"4","author":"Hollingsworth","year":"2019","journal-title":"NPJ Vaccines"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0246","article-title":"Perioperative Influenza Vaccination Reduces Postoperative Metastatic Disease by Reversing Surgery-Induced Dysfunction in Natural Killer Cells","volume":"19","author":"Tai","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1904022116","article-title":"Intratumoral Injection of the Seasonal Flu Shot Converts Immunologically Cold Tumors to Hot and Serves as an Immunotherapy for Cancer","volume":"117","author":"Newman","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat5025","article-title":"Repurposing Rotavirus Vaccines for Intratumoral Immunotherapy Can Overcome Resistance to Immune Checkpoint Blockade","volume":"11","author":"Shekarian","year":"2019","journal-title":"Sci Transl Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000443","article-title":"Repurposing Infectious Disease Vaccines for Intratumoral Immunotherapy","volume":"8","author":"Melero","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.1748","article-title":"Combined Systemic and Intratumoral Administration of Human Papillomavirus Vaccine to Treat Multiple Cutaneous Basaloid Squamous Cell Carcinomas","volume":"154","author":"Nichols","year":"2018","journal-title":"JAMA Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2017.06.007","article-title":"Repurposing Drugs in Oncology: Next Steps","volume":"3","author":"Verbaanderd","year":"2017","journal-title":"Trends Cancer"},{"key":"B15","unstructured":"Vaccines Licensed for Use in the United States"},{"key":"B16","unstructured":"Download Medicine Data"},{"key":"B17","unstructured":"Vaccines & Diseases"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.01.008","article-title":"Repurposing Drugs in Oncology: From Candidate Selection to Clinical Adoption","volume":"68","author":"Pantziarka","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4558","article-title":"Oncolytic Measles Virus in Cutaneous T-Cell Lymphomas Mounts Antitumor Immune Responses in Vivo and Targets Interferon-Resistant Tumor Cells","volume":"106","author":"Heinzerling","year":"2005","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1221","article-title":"Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses","volume":"18","author":"Noonan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0276","article-title":"Combination Chemotherapy and ALVAC-CEA\/B7.1 Vaccine in Patients With Metastatic Colorectal Cancer","volume":"14","author":"Kaufman","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nature14320","article-title":"Tetanus Toxoid and CCL3 Improve Dendritic Cell Vaccines in Mice and Glioblastoma Patients","volume":"519","author":"Mitchell","year":"2015","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-016-1796-7","article-title":"Prophylactic Vaccines are Potent Activators of Monocyte-Derived Dendritic Cells and Drive Effective Anti-Tumor Responses in Melanoma Patients At the Cost of Toxicity","volume":"65","author":"Bol","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12071802","article-title":"Mycobacteria-Based Vaccines as Immunotherapy for Non-Urological Cancers","volume":"12","author":"Noguera-Ortega","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1993.tb00989.x","article-title":"Pooled Analysis of the Efficacy of Bacille Calmette-Guerin (BCG) Immunotherapy in Malignant Melanoma","volume":"19","author":"Tan","year":"1993","journal-title":"J Dermatol Surg Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-019-10057-0","article-title":"Mycobacterium Bovis BCG in Metastatic Melanoma Therapy","volume":"103","author":"Benitez","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/joim.13037","article-title":"Clinical and Molecular Insights Into BCG Immunotherapy for Melanoma","volume":"288","author":"Kremenovic","year":"2020","journal-title":"J Intern Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh220","article-title":"Randomized Trial of Adjuvant Therapy in Colon Carcinoma: 10-Year Results of NSABP Protocol C-01","volume":"96","author":"Smith","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.14.0095","article-title":"Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival\u2013a Report From the Children\u2019s Oncology Group","volume":"26","author":"Meyers","year":"2008","journal-title":"J Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1006\/clim.1999.4820","article-title":"Immunological Effects of BCG as an Adjuvant in Autologous Tumor Vaccines","volume":"94","author":"Li","year":"2000","journal-title":"Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.1.148","article-title":"Adjuvant Active Specific Immunotherapy for Stage II and III Colon Cancer With an Autologous Tumor Cell Vaccine: Eastern Cooperative Oncology Group Study E5283","volume":"18","author":"Harris","year":"2000","journal-title":"J Clin Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.17.186","article-title":"Phase III Study of Adjuvant Vaccination With Bec2\/Bacille Calmette-Guerin in Responding Patients With Limited-Disease Small-Cell Lung Cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study)","volume":"23","author":"Giaccone","year":"2005","journal-title":"J Clin Oncol"},{"key":"B33","first-page":"5","article-title":"Effects of Desialylation of Ovine Submaxillary Gland Mucin (OSM) on Humoral and Cellular Immune Responses to Tn and Sialylated Tn","volume":"6","author":"O\u2019Boyle","year":"2006","journal-title":"Cancer Immun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/01.cji.0000208258.79005.5f","article-title":"A Phase I Study of an Allogeneic Cell Vaccine (VACCIMEL) With GM-CSF in Melanoma Patients","volume":"29","author":"Barrio","year":"2006","journal-title":"J Immunother"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-9056(06)60300-X","article-title":"Phase I Study With an Autologous Tumor Cell Vaccine for Locally Advanced or Metastatic Prostate Cancer","volume":"10","author":"Berger","year":"2007","journal-title":"J Pharm Pharm Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3892\/or_00000027","article-title":"Immunotherapy With Irradiated Autologous Leukemic Cells in Patients With B-CLL in Early Stages","volume":"20","author":"Hus","year":"2008","journal-title":"Oncol Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2008.02140.x","article-title":"A New Strategy to Induce Effective Antitumour Response in Vitro and in Vivo","volume":"68","author":"Wang","year":"2008","journal-title":"Scand J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-251884","article-title":"Commonly Used Prophylactic Vaccines as an Alternative for Synthetically Produced TLR Ligands to Mature Monocyte-Derived Dendritic Cells","volume":"116","author":"Schreibelt","year":"2010","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1038\/bcj.2012.19","article-title":"Enhancement of Myeloma Development Mediated Though Myeloma Cell-Th2 Cell Interactions After Microbial Antigen Presentation by Myeloma Cells and DCs","volume":"2","author":"Tian","year":"2012","journal-title":"Blood Cancer J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1023\/a:100645642117","article-title":"A Pilot Study of Autologous Cancer Cell Vaccination and Cellular Immunotherapy Using Anti-CD3 Stimulated Lymphocytes in Patients With Recurrent Grade III\/IV Astrocytoma","volume":"48","author":"Wood","year":"2000","journal-title":"J Neurooncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s002620050019","article-title":"Observed Localization of the Long-Term Cultured Rat Adherent Natural Killer Cells in Mammary Tumor Tissues","volume":"48","author":"Gu","year":"2000","journal-title":"Cancer Immunol Immunother"},{"key":"B42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10434-001-0389-6","article-title":"CancerVax, an Allogeneic Tumor Cell Vaccine, Induces Specific Humoral and Cellular Immune Responses in Advanced Colon Cancer","volume":"8","author":"Habal","year":"2001","journal-title":"Ann Surg Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600254","article-title":"A Phase II Study of Active Specific Immunotherapy and 5-FU\/Leucovorin as Adjuvant Therapy for Stage III Colon Carcinoma","volume":"86","author":"Baars","year":"2002","journal-title":"Br J Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/hed.10195","article-title":"Generation of Vaccine-Primed Lymphocytes for the Treatment of Head and Neck Cancer","volume":"25","author":"Chang","year":"2003","journal-title":"Head Neck"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-200303000-00009","article-title":"Identification of Tumor-Specific Antibodies in Patients With Breast Cancer Vaccinated With Gene-Modified Allogeneic Tumor Cells","volume":"26","author":"Dols","year":"2003","journal-title":"J Immunother"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0345","article-title":"Sequential Immunization of Melanoma Patients With GD3 Ganglioside Vaccine and Anti-Idiotypic Monoclonal Antibody That Mimics GD3 Ganglioside","volume":"10","author":"Chapman","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.015","article-title":"Immunotherapy With Autologous Tumor Cell-BCG Vaccine in Patients With Colon Cancer: A Prospective Study of Medical and Economic Benefits","volume":"23","author":"Uyl-de Groot","year":"2005","journal-title":"Vaccine"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.3.4.221","article-title":"Lung Cancer Immunotherapy","volume":"3","author":"Raez","year":"2005","journal-title":"Clin Med Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.amjsurg.2016.06.008","article-title":"Surgical Immune Interventions for Solid Malignancies","volume":"212","author":"Zeltsman","year":"2016","journal-title":"Am J Surg"},{"key":"B50","article-title":"Therapeutic Response of Untreatable Hepatocellular Carcinoma After Application of the Immune Modulators IL-2, BCG and Melatonin","volume":"33","author":"Tomov","year":"2013","journal-title":"Anticancer Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00411","article-title":"Autoantibodies May Predict Immune-Related Toxicity: Results From a Phase I Study of Intralesional Bacillus Calmette-Gu\u00e9rin Followed by Ipilimumab in Patients With Advanced Metastatic Melanoma","volume":"9","author":"Da Gama Duarte","year":"2018","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.rvsc.2020.08.008","article-title":"Efficacy of BCG Vaccine and Mitomycin C for the Treatment of Ocular Squamous Cell Carcinoma in Bovines","volume":"133","author":"Podarala","year":"2020","journal-title":"Res Vet Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-5224.2004.04027.x","article-title":"Periocular Sarcoid in a Horse","volume":"7","author":"Kom\u00e1romy","year":"2004","journal-title":"Vet Ophthalmol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/vr.149.22.665","article-title":"Evaluation of Excision, Cryosurgery and Local BCG Vaccination for the Treatment of Equine Sarcoids","volume":"149","author":"Martens","year":"2001","journal-title":"Vet Rec"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2460\/javma.249.3.311","article-title":"Treatment of Sarcoids in Equids: 230 Cases (2008-2013)","volume":"249","author":"Haspeslagh","year":"2016","journal-title":"J Am Vet Med Assoc"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.68.11.1246","article-title":"Evaluation of a Novel Immunomodulator Composed of Human Chorionic Gonadotropin and Bacillus Calmette-Guerin for Treatment of Canine Mast Cell Tumors in Clinically Affected Dogs","volume":"68","author":"Henry","year":"2007","journal-title":"Am J Vet Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4102\/jsava.v80i2.178","article-title":"Combination Therapy Using Intratumoral Bacillus Calmette-Guerin (BCG) and Vincristine in Dogs With Transmissible Venereal Tumours: Therapeutic Efficacy and Histological Changes","volume":"80","author":"Mukaratirwa","year":"2009","journal-title":"J S Afr Vet Assoc"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2007.03521.x","article-title":"Increase of CD4+ CD25+ Regulatory T Cells in the Peripheral Blood of Patients With Metastatic Carcinoma: A Phase I Clinical Trial Using Cyclophosphamide and Immunotherapy to Eliminate CD4+ CD25+ T Lymphocytes","volume":"150","author":"Audia","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2004.03.035","article-title":"Age-Dependent Differences in the Efficacy of Cancer Immunotherapy in C57BL and AKR Mouse Strains","volume":"39","author":"Kaptzan","year":"2004","journal-title":"Exp Gerontol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-008-0520-7","article-title":"Effect of BCG Stimulus on Proinflammatory Cytokine Production in Laryngeal Cancer","volume":"58","author":"Conti-Freitas","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.306","article-title":"Supernatants From Lymphocytes Stimulated With Bacillus Calmette-Guerin Can Modify the Antigenicity of Tumours and Stimulate Allogeneic T-Cell Responses","volume":"105","author":"Liu","year":"2011","journal-title":"Br J Cancer"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.10.008","article-title":"BCG Immune Activation Reduces Growth and Angiogenesis in an in Vitro Model of Head and Neck Squamous Cell Carcinoma","volume":"35","author":"S\u00e1nchez-Rodr\u00edguez","year":"2017","journal-title":"Vaccine"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.14715\/cmb\/2018.64.6.3","article-title":"Bacillus Calmette Gu\u00e9rin (BCG) Activates Lymphocyte to Promote Autophagy and Apoptosis of Gastric Cancer MGC-803 Cell","volume":"64","author":"Yao","year":"2018","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-011-1121-4","article-title":"Mycobacteria Activate Gammadelta T-Cell Anti-Tumour Responses Via Cytokines From Type 1 Myeloid Dendritic Cells: A Mechanism of Action for Cancer Immunotherapy","volume":"61","author":"Fowler","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2012.13.6.2935","article-title":"Biological Response Modifiers Influence Structure Function Relationship of Hematopoietic Stem and Stromal Cells in a Mouse Model of Leukemia","volume":"13","author":"Basu","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2014.09.002","article-title":"Combination Radiofrequency Ablation and Local Injection of the Immunostimulant Bacillus Calmette-Gu\u00e9rin Induces Antitumor Immunity in the Lung and At a Distant VX2 Tumor in a Rabbit Model","volume":"26","author":"Hamamoto","year":"2015","journal-title":"J Vasc Interv Radiol [Internet]"},{"key":"B67","first-page":"2","article-title":"[Squamous Cell Carcinoma in Ulcer After Bacille Calmette-Gu\u00e9rin Vaccination]","volume":"176","author":"Nielsen","year":"2014","journal-title":"Ugeskr Laeger"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2013.2137","article-title":"Squamous Cell Carcinoma Possibly Originating From a Granuloma Following Vaccination With Bacille Calmette-Gu\u00e9rin","volume":"23","author":"Fujisawa","year":"2013","journal-title":"Eur J Dermatol"},{"key":"B69","article-title":"Basal Cell Carcinoma Arising in a Bacille Calmette-Gu\u00e9rin Vaccination Scar","volume":"89","author":"Kluger","year":"2012","journal-title":"Cutis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.03930.x","article-title":"Basal Cell Carcinoma in a Bacillus Calmette-Gu\u00e9rin Scar","volume":"48","author":"Polat","year":"2009","journal-title":"Int J Dermatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2011.05387.x","article-title":"Tuberculosis and Cancer on a BCG Vaccination Site: An Instance of Immunocompromised District","volume":"53","author":"Lo Schiavo","year":"2014","journal-title":"Int J Dermatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04820.x","article-title":"BCG-Induced Lupus Vulgaris Complicated by Squamous Cell Carcinoma in a 7-Year-Old Child","volume":"50","author":"Thakur","year":"2011","journal-title":"Int J Dermatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2012.1887","article-title":"Tufted Angioma Arising At a Site of BCG Vaccination","volume":"23","author":"Zeng","year":"2013","journal-title":"Eur J Dermatol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14598","article-title":"Development of Kasabach-Merritt Phenomenon Following Vaccination: More Than a Coincidence","volume":"45","author":"Ji","year":"2018","journal-title":"J Dermatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2011.117","article-title":"Chemotherapeutically Induced Cutaneous Tuberculosis After BCG Injection in a Patient With Pelvic Osteosarcoma","volume":"13","author":"Zoccali","year":"2012","journal-title":"Surg Infect (Larchmt)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1053\/j.gastro.2017.09.009","article-title":"Cholera Vaccine Use is Associated With a Reduced Risk of Death in Patients With Colorectal Cancer: A Population-Based Study","volume":"154","author":"Ji","year":"2018","journal-title":"Gastroenterology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/s41467-018-04814-4","article-title":"Association Between Post-Diagnostic Use of Cholera Vaccine and Risk of Death in Prostate Cancer Patients","volume":"9","author":"Ji","year":"2018","journal-title":"Nat Commun"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41416-020-01108-9","article-title":"Association of Post-Diagnostic Use of Cholera Vaccine With Survival Outcome in Breast Cancer Patients","author":"Zheng","year":"2020","journal-title":"Br J Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.5.3522","article-title":"Oral Administration of Recombinant Cholera Toxin Subunit B Inhibits IL-12-Mediated Murine Experimental (Trinitrobenzene Sulfonic Acid) Colitis","volume":"166","author":"Boirivant","year":"2001","journal-title":"J Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgu325","article-title":"Cholera-Toxin Suppresses Carcinogenesis in a Mouse Model of Inflammation-Driven Sporadic Colon Cancer","volume":"36","author":"Doulberis","year":"2015","journal-title":"Carcinogenesis"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/toxins7030974","article-title":"Cholera Toxin B: One Subunit With Many Pharmaceutical Applications","volume":"7","author":"Baldauf","year":"2015","journal-title":"Toxins (Basel)"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3747\/co.20.1212","article-title":"Spontaneous Regression of Metastatic Melanoma After Inoculation With Tetanus-Diphtheria-Pertussis Vaccine","volume":"20","author":"Tran","year":"2013","journal-title":"Curr Oncol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/1440-1681.13096","article-title":"Could Hepatitis B Vaccine Act as an Adjuvant to Lower Risk and Relapses of Cancer","volume":"46","author":"Altinoz","year":"2019","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj092","article-title":"Human Papillomavirus Infection and Incidence of Squamous Cell and Basal Cell Carcinomas of the Skin","volume":"98","author":"Karagas","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.4530","article-title":"Association Between \u03b2-Genus Human Papillomavirus and Cutaneous Squamous Cell Carcinoma in Immunocompetent Individuals-a Meta-Analysis","volume":"152","author":"Chahoud","year":"2016","journal-title":"JAMA Dermatol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2016.5703","article-title":"Association of Human Papillomavirus Vaccine With the Development of Keratinocyte Carcinomas","volume":"153","author":"Nichols","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.1485","article-title":"Human Papillomavirus Vaccination and Keratinocyte Carcinomas","volume":"153","author":"Mayer","year":"2017","journal-title":"JAMA Dermatol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.02.002","article-title":"Systemic and Intratumoral 9-Valent Human Papillomavirus Vaccine Treatment for Squamous Cell Carcinoma in Situ in a Renal Transplant Recipient","volume":"6","author":"Nichols","year":"2020","journal-title":"JAAD Case Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"148","DOI":"10.25251\/skin.4.2.9","article-title":"The Successful Treatment of Multiple Cutaneous Malignancies With HPV Vaccination: Case Report","volume":"4","author":"Geizhals","year":"2020","journal-title":"Skin J Cutan Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.3789","article-title":"Use of Combination Systemic-Intratumoral HPV Vaccine to Treat Cutaneous Basaloid Squamous Cell Carcinomas","volume":"155","author":"Brunet-Possenti","year":"2019","journal-title":"JAMA Dermatol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2012-100414","article-title":"Effect of the Human Papillomavirus (HPV) Quadrivalent Vaccine in a Subgroup of Women With Cervical and Vulvar Disease: Retrospective Pooled Analysis of Trial Data","volume":"38","author":"Lopes","year":"2012","journal-title":"J Fam Plan Reprod Health Care"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.04.050","article-title":"Is Vaccination With Quadrivalent HPV Vaccine After Loop Electrosurgical Excision Procedure Effective in Preventing Recurrence in Patients With High-Grade Cervical Intraepithelial Neoplasia (CIN2-3)","volume":"130","author":"Kang","year":"2013","journal-title":"Gynecol Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir1036","article-title":"Prevention of Recurrent High-Grade Anal Neoplasia With Quadrivalent Human Papillomavirus Vaccination of Men Who Have Sex With Men: A Nonconcurrent Cohort Study","volume":"54","author":"Swedish","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B94","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4161\/hv.5.10.9515","article-title":"Evaluation of Quadrivalent HPV 6\/11\/16\/18 Vaccine Efficacy Against Cervical and Anogenital Disease in Subjects With Serological Evidence of Prior Vaccine Type HPV Infection","volume":"5","author":"Olsson","year":"2009","journal-title":"Hum Vaccin"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.07.055","article-title":"Prophylactic HPV Vaccination After Conization: A Systematic Review and Meta-Analysis","volume":"38","author":"Jentschke","year":"2020","journal-title":"Vaccine"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.0819","article-title":"Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA)","volume":"2","author":"Karita","year":"2019","journal-title":"JAMA Netw Open"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.93","article-title":"Vulval Cancer and HPV Vaccination in Recurrent Disease","volume":"2","author":"Gustafson","year":"2014","journal-title":"Clin Case Rep"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-020-00305-8","article-title":"Evidence for a Causal Role by Human Papillomaviruses in Prostate Cancer - a Systematic Review","volume":"15","author":"Lawson","year":"2020","journal-title":"Infect Agent Cancer"},{"key":"B99","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1158\/0008-5472.CAN-12-1993","article-title":"Preventing Postoperative Metastatic Disease by Inhibiting Surgery-Induced Dysfunction in Natural Killer Cells","volume":"73","author":"Tai","year":"2013","journal-title":"Cancer Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e26618","DOI":"10.4161\/onci.26618","article-title":"Preventing Surgery-Induced NK Cell Dysfunction and Cancer Metastases With Influenza Vaccination","volume":"2","author":"Tai","year":"2013","journal-title":"Oncoimmunology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e1431082","DOI":"10.1080\/2162402X.2018.1431082","article-title":"Phosphodiesterase-5 Inhibition Reduces Postoperative Metastatic Disease by Targeting Surgery-Induced Myeloid Derived Suppressor Cell-Dependent Inhibition of Natural Killer Cell Cytotoxicity","volume":"7","author":"Tai","year":"2018","journal-title":"Oncoimmunology"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33340","article-title":"Association of Postoperative Influenza Vaccine on Overall Mortality in Patients Undergoing Curative Surgery for Solid Tumors","volume":"148","author":"G\u00f6genur","year":"2020","journal-title":"Int J Cancer"},{"key":"B103","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40425-018-0353-7","article-title":"Influenza Vaccination of Cancer Patients During PD-1 Blockade Induces Serological Protection But May Raise the Risk for Immune-Related Adverse Events","volume":"6","author":"L\u00e4ubli","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.19.00495","article-title":"Safety of Influenza Vaccine in Patients With Cancer Receiving Pembrolizumab","volume":"16","author":"Failing","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2018-0080","article-title":"Influenza Vaccine Indication During Therapy With Immune Checkpoint Inhibitors: A Transversal Challenge. the Invidia Study","volume":"10","author":"Bersanelli","year":"2018","journal-title":"Immunotherapy"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz202","article-title":"Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors","volume":"70","author":"Chong","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2019-0180","article-title":"Impact of Influenza Syndrome and Flu Vaccine on Survival of Cancer Patients During Immunotherapy in the INVIDIa Study","volume":"12","author":"Bersanelli","year":"2020","journal-title":"Immunotherapy"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e17591","article-title":"Impact of Flu Vaccine on Survival After Immunotherapy for Metastatic Castration Resistant Prostate Cancer (mCRPC): Analysis of Medicare Claims Data","volume":"38","author":"Pachynski","year":"2020","journal-title":"J Clin Oncol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"617293","DOI":"10.5402\/2011\/617293","article-title":"Extranodal MALT Lymphoma of the Right Triceps Muscle Following Influenza Vaccine Injection: A Rare Case With an Interesting Presentation","volume":"2011","author":"Edwards-Bennett","year":"2011","journal-title":"ISRN Hematol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.coviro.2020.07.016","article-title":"Measles Virus in Cancer Therapy","volume":"41","author":"M\u00fchlebach","year":"2020","journal-title":"Curr Opin Virol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)92086-1","article-title":"Regression of Burkitt\u2019S Lymphoma in Association With Measles Infection","volume":"298","author":"Bluming","year":"1971","journal-title":"Lancet"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(71)91186-X","article-title":"Hodgkin\u2019s Disease: Remissions After Measles","volume":"297","author":"Zygiert","year":"1971","journal-title":"Lancet"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/S0140-6736(81)92286-8","article-title":"Regression of Hodgkin\u2019S Disease After Measles","volume":"317","author":"Taqi","year":"1981","journal-title":"Lancet"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2006.03.002","article-title":"Oncolytic Measles Virus Targets High CD46 Expression on Multiple Myeloma Cells","volume":"34","author":"Ong","year":"2006","journal-title":"Exp Hematol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0884","article-title":"High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus","volume":"64","author":"Anderson","year":"2004","journal-title":"Cancer Res"},{"key":"B116","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3390\/biology2020587","article-title":"Antitumor Virotherapy by Attenuated Measles Virus (MV)","volume":"2","author":"Guillerme","year":"2013","journal-title":"Biology (Basel)"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.2174\/138920112800958896","article-title":"Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics","volume":"13","author":"Msaouel P","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v8100294","article-title":"Measles to the Rescue: A Review of Oncolytic Measles Virus","volume":"8","author":"Aref","year":"2016","journal-title":"Viruses"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.4.10.1685","article-title":"Oncolytic Measles Viruses for Cancer Therapy","volume":"4","author":"Nakamura","year":"2004","journal-title":"Expert Opin Biol Ther"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.455","article-title":"Measles as a Potential Oncolytic Virus","volume":"15","author":"Fielding","year":"2005","journal-title":"Rev Med Virol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.7.2002","article-title":"Systemic Therapy of Myeloma Xenografts by an Attenuated Measles Virus","volume":"98","author":"Peng","year":"2001","journal-title":"Blood"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.12.3746","article-title":"Live Attenuated Measles Virus Induces Regression of Human Lymphoma Xenografts in Immunodeficient Mice","volume":"97","author":"Grote","year":"2001","journal-title":"Blood"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.08.034","article-title":"Combination of Vaccine-Strain Measles and Mumps Virus Synergistically Kills a Wide Range of Human Hematological Cancer Cells: Special Focus on Acute Myeloid Leukemia","volume":"354","author":"Zhang","year":"2014","journal-title":"Cancer Lett"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2019.12.015","article-title":"Attenuated Measles Vaccine Strain Have Potent Oncolytic Activity Against Iraqi Patient Derived Breast Cancer Cell Line","volume":"27","author":"Abdullah","year":"2020","journal-title":"Saudi J Biol Sci"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13521","article-title":"Combination of Vaccine Strain Measles Virus and Nimotuzumab in the Treatment of Laryngeal Cancer","volume":"39","author":"Toan","year":"2019","journal-title":"Anticancer Res"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3109\/01902140902853176","article-title":"Measles Virus: Evidence for Association With Lung Cancer","volume":"35","author":"Sion-vardy","year":"2009","journal-title":"Exp Lung Res"},{"key":"B127","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3892\/or.2012.2109","article-title":"Live Attenuated Measles Virus Vaccine Induces Apoptosis and Promotes Tumor Regression in Lung Cancer","volume":"29","author":"Zhao","year":"2013","journal-title":"Oncol Rep"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2720-7","article-title":"Protective Immunity Elicited by Measles Vaccine Exerts Anti-Tumor Effects on Measles Virus Hemagglutinin Gene-Modified Cancer Cells in a Mouse Model","volume":"144","author":"Qi","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700823","article-title":"Oncolytic Activities of Approved Mumps and Measles Vaccines for Therapy of Ovarian Cancer","volume":"12","author":"Myers","year":"2005","journal-title":"Cancer Gene Ther"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1080\/07357907.2018.1434539","article-title":"Combination of Vaccine-Strain Measles and Mumps Viruses Enhances Oncolytic Activity Against Human Solid Malignancies","volume":"36","author":"Son","year":"2018","journal-title":"Cancer Invest"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197412)34:6<1907::AID-CNCR2820340609>3.0.CO;2-4","article-title":"Treatment of Human Cancer With Mumps Virus","volume":"34","author":"Asada","year":"1974","journal-title":"Cancer"},{"key":"B132","first-page":"37","article-title":"Studies on the Use of Mumps Virus for Treatment of Human Cancer","volume":"21","author":"Okuno","year":"1978","journal-title":"Biken J"},{"key":"B133","article-title":"Immunotherapy of Advanced Gynecologic Cancer Patients Utilizing Mumps Virus","volume":"12","author":"Shimizu","year":"1988","journal-title":"Cancer Detect Prev"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.08.010","article-title":"Protection Against Melanoma by Vaccination With Bacille Calmette-Gu\u00e9rin (BCG) and\/or Vaccinia: An Epidemiology-Based Hypothesis on the Nature of a Melanoma Risk Factor and Its Immunological Control","volume":"41","author":"Krone","year":"2005","journal-title":"Eur J Cancer"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2007.tb03957.x","article-title":"Potent CTL Induction by a Whole Cell Pertussis Vaccine in Anti-Tumor Peptide Immunotherapy","volume":"51","author":"Yano","year":"2007","journal-title":"Microbiol Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e0147666","DOI":"10.1371\/journal.pone.0147666","article-title":"Experimental Adaptation of Rotaviruses to Tumor Cell Lines","volume":"11","author":"Guerrero","year":"2016","journal-title":"PloS One"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-199910000-00011","article-title":"Infections and Melanoma Risk","volume":"9","author":"K\u00f6lmel","year":"1999","journal-title":"Melanoma Res"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.00643.x","article-title":"Inverse Association Between Melanoma and Previous Vaccinations Against Tuberculosis and Smallpox: Results of the FEBIM Study","volume":"119","author":"Pfahlberg","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.09.023","article-title":"Smallpox and BCG Vaccination in Childhood and Cutaneous Malignant Melanoma in Danish Adults Followed From 18 to 49 Years","volume":"37","author":"Rieckmann","year":"2019","journal-title":"Vaccine"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.09.023","article-title":"Prior Immunisation of Patients With Malignant Melanoma With Vaccinia or BCG is Associated With Better Survival. An European Organization for Research and Treatment of Cancer Cohort Study on 542 Patients","volume":"41","author":"K\u00f6lmel","year":"2005","journal-title":"Eur J Cancer"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0175","article-title":"Does Childhood Vaccination and Exposure to Infection Improve Long-Term Survival in Patients With Malignant Melanoma","volume":"2","author":"Tarhini","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.12.094","article-title":"Adjuvant Immunotherapy of Patients With High-Risk Melanoma Using Vaccinia Viral Lysates of Melanoma: Results of a Randomized Trial","volume":"20","author":"Hersey","year":"2002","journal-title":"J Clin Oncol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1072-7515(98)00097-0","article-title":"Surgical Adjuvant Active Specific Immunotherapy for Patients With Stage III Melanoma: The Final Analysis of Data From a Phase III, Randomized, Double-Blind, Multicenter Vaccinia Melanoma Oncolysate Trial","volume":"187","author":"Wallack","year":"1998","journal-title":"J Am Coll Surg"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.08.103","article-title":"Risk of Lymphoma and Leukaemia After Bacille Calmette-Gu\u00e9rin and Smallpox Vaccination: A Danish Case-Cohort Study","volume":"27","author":"Villumsen","year":"2009","journal-title":"Vaccine"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1007\/s002620000146","article-title":"Phase I Clinical Trial of a Recombinant Canarypoxvirus (ALVAC) Vaccine Expressing Human Carcinoembryonic Antigen and the B7.1 Co-Stimulatory Molecule","volume":"49","author":"H\u00f6rig","year":"2000","journal-title":"Cancer Immunol Immunother"},{"key":"B146","doi-asserted-by":"publisher","first-page":"clincanres.1082.2020","DOI":"10.1158\/1078-0432.CCR-20-1082","article-title":"Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine (Trials Targeting Cytomegalovirus in Glioblastoma","author":"Batich","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2062","article-title":"Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy","volume":"80","author":"T\u00e4htinen","year":"2020","journal-title":"Cancer Res"},{"key":"B148","doi-asserted-by":"publisher","first-page":"e1265720","DOI":"10.1080\/2162402X.2016.1265720","article-title":"Preclinical Efficacy and Safety of the Ty21a Vaccine Strain for Intravesical Immunotherapy of Non-Muscle-Invasive Bladder Cancer","volume":"6","author":"Domingos-Pereira","year":"2017","journal-title":"Oncoimmunology"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0671","article-title":"Intravesical Ty21a Vaccine Promotes Dendritic Cells and T Cell\u2013Mediated Tumor Regression in the MB49 Bladder Cancer Model","volume":"7","author":"Domingos-Pereira","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2011.07.001","article-title":"A Pilot Case-Cohort Study of Liver and Pancreatic Cancers in Poultry Workers","volume":"21","author":"Felini","year":"2011","journal-title":"Ann Epidemiol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2138","article-title":"Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells","volume":"23","author":"Tanaka","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.201910375","article-title":"Repurposing the Yellow Fever Vaccine for Intratumoral Immunotherapy","volume":"12","author":"Aznar","year":"2020","journal-title":"EMBO Mol Med"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000333","article-title":"Yellow Fever Vaccine 17D Administered to Healthy Women Aged Between 40 and 54 Years Halves Breast Cancer Risk: An Observational Study","volume":"27","author":"Mastrangelo","year":"2018","journal-title":"Eur J Cancer Prev"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.10.076","article-title":"Does Yellow Fever 17D Vaccine Protect Against Melanoma","volume":"27","author":"Mastrangelo","year":"2009","journal-title":"Vaccine"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.04.074","article-title":"The Yellow Fever 17D Vaccine and Risk of Malignant Melanoma in the United States Military","volume":"30","author":"Hodges-Vazquez","year":"2012","journal-title":"Vaccine"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051720","article-title":"Yellow Fever Vaccine YF-17D Activates Multiple Dendritic Cell Subsets Via TLR2, 7, 8, and 9 to Stimulate Polyvalent Immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J Exp Med"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082292","article-title":"Yellow Fever Vaccine Induces Integrated Multilineage and Polyfunctional Immune Responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"key":"B158","doi-asserted-by":"publisher","first-page":"805629","DOI":"10.1155\/2012\/805629","article-title":"Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles","volume":"2012","author":"Ferguson","year":"2012","journal-title":"Adv Virol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-3266","article-title":"Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus From Neutralization","volume":"17","author":"Ilett","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1510","article-title":"Cyclophosphamide Facilitates Antitumor Efficacy Against Subcutaneous Tumors Following Intravenous Delivery of Reovirus","volume":"14","author":"Qiao","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.2830","article-title":"Effective Multiple Oral Administration of Reverse Genetics Engineered Infectious Bursal Disease Virus in Mice in the Presence of Neutralizing Antibodies: Characterization of IBDV","volume":"17","author":"Horny\u00e1k","year":"2015","journal-title":"J Gene Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.688755\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T10:26:43Z","timestamp":1620901603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.688755\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":161,"alternative-id":["10.3389\/fonc.2021.688755"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.688755","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,13]]},"article-number":"688755"}}